Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA’s dietary supplement program chief raised eyebrows at a botanical products conference citing low estimates on rates of compliance with the good manufacturing practices final rule and the new dietary ingredient notification requirements, as well as adverse event reporting.